Likewise, it was shown that resveratrol plays a similar role in the induction of immunogenic cell death through the expression of calreticulin (CRT) and high mobility group box 1 (HMGB1) on the surface of ovarian cancer cells and results in the significant inhibition of tumour volume and suppression of the tumour growth factor (TGF)-β while promoting levels of IL-12 and IFN-γ [11,17,18,26]. The gene discussed is HMGB1; the disease is ovarian carcinoma.